Suchergebnisse - "Chiu, Yi-Lin"

PubPharm (6)

1

A phase 1 study to evaluate effect of food on veliparib pharmacokinetics and relative bioavailability in subjects with solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Mostafa, N. | Chiu, Y. | Rosen, L. | +3

2

Results of a phase 1, randomized study evaluating the effects of food and diurnal variation on the pharmacokinetics of linifanib

enthalten in: Cancer chemotherapy and pharmacology | 2014

von Xiong, H. | Chiu, Y. | Ricker, J. | +1

3

Exposure-response (safety) analysis to identify linifanib dose for a Phase III study in patients with hepatocellular carcinoma

enthalten in: Clinical therapeutics | 2013

von Chiu, Y. | Carlson, D. | Pradhan, R. | +1

4

Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development : the example of the novel anticancer agent ABT-751

enthalten in: Pharmacogenetics and genomics | 2013

von Innocenti, F. | Ramírez, J. | Obel, J. | +18

5

An open-label, phase 1 study evaluating safety, tolerability, and pharmacokinetics of linifanib (ABT-869) in Japanese patients with solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2012

von Asahina, H. | Tamura, Y. | Nokihara, H. | +15

6

Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies : a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity

enthalten in: The Lancet. Oncology | 2010

von Wilson, W. | O'Connor, O. | Czuczman, M. | +14

1
[1]